FUNDAMENTALS · Fundamentals · TW Healthcare

Ma Kuang Healthcare Holding (4139) Fundamentals 2026 — Revenue Analysis | SniperIQ

Ma Kuang Healthcare Holding (4139) is a TW-listed Healthcare company in Medical - Care Facilities with a market capitalization of NT

.9B, trading at NT$42.00 on the TWO. This SniperIQ fundamentals page covers Ma Kuang Healthcare Holding's valuation, profitability (net margin -7.7%), revenue (NT
.1B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapNT
.9B
Net Margin-7.7%
Revenue (FY25)NT
.1B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Ma Kuang Healthcare Holding's market cap?

Ma Kuang Healthcare Holding (4139) has a market capitalization of approximately NT

.9B, trading at NT$42.00 on the TWO. Market cap moves with the live share price.

What is Ma Kuang Healthcare Holding's P/E ratio?

Ma Kuang Healthcare Holding's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 4.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Ma Kuang Healthcare Holding?

Ma Kuang Healthcare Holding runs a net profit margin of -7.7%, a gross margin of 11.5%, and an operating margin of -3.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Ma Kuang Healthcare Holding generate?

Ma Kuang Healthcare Holding reported revenue of NT

.1B for fiscal year 2025, with net income of -NT$67M and earnings per share (EPS) of -1.55. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Ma Kuang Healthcare Holding pay a dividend?

Ma Kuang Healthcare Holding does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Ma Kuang Healthcare Holding financially healthy?

Ma Kuang Healthcare Holding carries a debt-to-equity ratio of 1.49x and a current ratio of 0.50x, with a market beta of -0.34. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Ma Kuang Healthcare Holding a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Ma Kuang Healthcare Holding (4139) the key facts are: market cap NT

.9B, revenue NT
.1B, 52-week range 21-42.8. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Ma Kuang Healthcare Holding's full fundamentals live

Get Ma Kuang Healthcare Holding's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Ocular Therapeutix (OCUL) fundamentals · Omnicell (OMCL) fundamentals · Lakefront Biotherapeutics (LKFT) fundamentals · Tyra Biosciences (TYRA) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons